| Name | 3,5-Dimethyl-4-nitropyridine |
|---|---|
| Synonyms |
Pyridine,3,5-dimethyl-4-nitro-
3,5-dimethyl-4-nitro-pyridine 4-Nitro-3,5-dimethyl-pyridin 4-nitro-3,5-dimethylpyridine MFCD09842456 |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 258.1±35.0 °C at 760 mmHg |
| Molecular Formula | C7H8N2O2 |
| Molecular Weight | 152.15100 |
| Flash Point | 109.9±25.9 °C |
| Exact Mass | 152.05900 |
| PSA | 58.71000 |
| LogP | 1.25 |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.551 |
| HS Code | 2933399090 |
|---|
|
~67%
89693-88-9 |
| Literature: BAYER PHARMACEUTICALS CORPORATION Patent: WO2007/27842 A1, 2007 ; Location in patent: Page/Page column 91-92 ; |
| Precursor 1 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |